PMID: 16517415Mar 7, 2006Paper

Antineoplastic treatment and venous thrombosis

Bulletin du cancer
Christophe Desauw, Jacques Bonneterre

Abstract

The risk of thrombosis is particularly high in cancer patients, due to many associated risk factors : surgery, immobilization, central venous access, elderly patients... Furthermore, cancer induces a state of hypercoagulability. Thrombophlebitis in this context carries a poor prognosis partially explained by the link with metastasis. Various treatments further increase the risk of thrombosis. Surgery is the most studied therapeutic modality increasing the incidence. Several medical treatments might synergize increasing the thrombosis rate up to 40% for some combinations. Anti-angiogenic treatments like VEGF inhibitors, thalidomide increase the risk of thrombosis. The curative treatment of thromboses has recently been improved; a treatment by LWMH only for 3 to 6 months gives the best results. LWMH for 4 weeks has been proposed as a preventive measure after surgery only; no preventive treatment can be proposed outside this situation.

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Related Papers

Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
Mirza JusufovicUlrike Waje-Andreassen
Critical Care Medicine
Ida MartinelliPier Mannuccio Mannucci
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
Nicholas SlamonDavid Rittenhouse
Seminars in Thrombosis and Hemostasis
Manish KohliPaulette Mehta
© 2021 Meta ULC. All rights reserved